Unknown

Dataset Information

0

Optimization of Peptidomimetics as Selective Inhibitors for the ?-Catenin/T-Cell Factor Protein-Protein Interaction.

ABSTRACT: The ?-catenin/T-cell factor (Tcf) protein-protein interaction (PPI) plays a critical role in the ?-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound 1, which was designed to target the Tcf4 G13ANDE17 binding site of ?-catenin, extensive structure-activity relationship studies have been conducted. As a result, compounds 53 and 57 were found to disrupt the ?-catenin/Tcf PPI with the Ki values of 0.64 and 0.44 ?M, respectively, and exhibit good selectivity for ?-catenin/Tcf over ?-catenin/E-cadherin and ?-catenin/adenomatous polyposis coli (APC) PPIs. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H-tetrazolium (MTS) cell viability assays revealed that 56, the ethyl ester of 53, was more potent than 53 in inhibiting viability of most of the Wnt/?-catenin hyperactive cancer cells. Further cell-based studies indicated that 56 disrupted the ?-catenin/Tcf PPI without affecting the ?-catenin/E-cadherin and ?-catenin/APC PPIs, suppressed transactivation of Wnt/?-catenin signaling in dose-dependent manners, and inhibited migration and invasiveness of Wnt/?-catenin-dependent cancer cells.

SUBMITTER: Wang Z 

PROVIDER: S-EPMC6931396 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction.

Wang Zhen Z   Zhang Min M   Wang Jin J   Ji Haitao H  

Journal of medicinal chemistry 20190321 7

The β-catenin/T-cell factor (Tcf) protein-protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound 1, which was designed to target the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site of β-catenin, extensive structure-activity relationship studies have been conducted. As a result, compounds 53 and 57 were found to disrupt the β-catenin/Tcf PPI with the K<sub>i</sub> values of 0.64 and 0.44 μM, resp  ...[more]

Similar Datasets

Unknown Structure-Based Optimization of Small-Molecule Inhibitors for the ?-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
| S-EPMC7787347 | biostudies-literature
Unknown Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.
| S-EPMC3962784 | biostudies-literature
Unknown Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.
| S-EPMC8366007 | biostudies-literature
Unknown Structure-Based Design of 1,4-Dibenzoylpiperazines as ?-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors.
| S-EPMC4867476 | biostudies-literature
Unknown High-Throughput Selectivity Assays for Small-Molecule Inhibitors of β-Catenin/T-Cell Factor Protein-Protein Interactions.
| S-EPMC4027448 | biostudies-literature
Unknown Structure-Guided Optimization of Replication Protein A (RPA)-DNA Interaction Inhibitors.
| S-EPMC7294550 | biostudies-literature
Unknown Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
| S-EPMC6561201 | biostudies-literature
Unknown Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
| S-EPMC8009417 | biostudies-literature
Unknown Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions.
| S-EPMC8170677 | biostudies-literature
Unknown TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.
| S-EPMC7689693 | biostudies-literature